TCP-MP-CA

• UNSPSC Description:

  TCP-MP-CA (compound 11a) is an inhibitor of LSD1 demethylation enzymatic via binding to LSD1/CoREST complex. TCP-MP-CA exhibits an inhibitory effect on osteoclastogenesis, with an IC50 value of 0.14 µM[1].

• Target Antigen:

  Histone Demethylase

• Type:

  Reference compound

• Related Pathways:

  Epigenetics

• Field of Research:

  Cancer

• Assay Protocol:

  https://www.medchemexpress.com/tcp-mp-ca.html

• Smiles:

  OC1=C(O)C=C(/C=C/C(N2CCC(CN[C@H]3[C@H](C4=CC=CC=C4)C3)CC2)=O)C=C1.Cl

• Molecular Weight:

  428.95

• References & Citations:

  [1]Zhihao Chen, et al. Discovery of TCP-(MP)-caffeic acid analogs as a new class of agents for treatment of osteoclastic bone loss. Bioorg Chem. 2024 Sep:150:107603.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported